• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用临床前数据作为预测人类脑组织靶向的工具。

Harnessing Preclinical Data as a Predictive Tool for Human Brain Tissue Targeting.

机构信息

Medicine Design, Medicinal Chemistry, Pfizer Worldwide R&D, 610 Main Street, Cambridge, Massachusetts 02139, United States.

Medicine Design, Pharmacokinetics, Dynamics, & Metabolism, Pfizer Worldwide R&D, Eastern Point Road, Groton, Connecticut 06340, United States.

出版信息

ACS Chem Neurosci. 2021 Mar 17;12(6):1007-1017. doi: 10.1021/acschemneuro.0c00807. Epub 2021 Mar 2.

DOI:10.1021/acschemneuro.0c00807
PMID:33651587
Abstract

One of the objectives within the medicinal chemistry discipline is to design tissue targeting molecules. The objective of tissue specificity can be either to gain drug access to the compartment of interest (, the CNS) for Neuroscience targets or to restrict drug access to the CNS for all other therapeutic areas. Both neuroscience and non-neuroscience therapeutic areas have struggled to quantitatively estimate brain penetration or the lack thereof with compounds that are substrates of efflux transport proteins such as P-glycoprotein (P-gp) and breast cancer resistant protein (BCRP) that are key components of the blood-brain barrier (BBB). It has been well established that drug candidates with high efflux ratios (ER) of these transporters have poor penetration into brain tissue. In the current work, we outline a parallel analysis to previously published models for the prediction of brain penetration that utilize an alternate MDR1-MDCK cell line as a better predictor of brain penetration and whether a correlation between , rodent data, non-human primate (NHP), and human brain penetration data could be established. Analysis of structural and physicochemical properties in conjunction with parameters and preclinical data has been highlighted in this manuscript as a continuation of the previously published work.

摘要

在药物化学学科中,一个目标是设计靶向组织的分子。组织特异性的目标可以是使药物进入感兴趣的部位(如 CNS),以用于神经科学靶点,或者限制药物进入 CNS,用于所有其他治疗领域。神经科学和非神经科学治疗领域都一直在努力定量估计化合物的脑穿透性,或者缺乏对脑穿透性的估计,这些化合物是外排转运蛋白(如 P-糖蛋白 (P-gp) 和乳腺癌耐药蛋白 (BCRP))的底物,这些蛋白是血脑屏障 (BBB) 的关键组成部分。已经证实,具有这些转运蛋白高外排比 (ER) 的药物候选物对脑组织的穿透性较差。在当前的工作中,我们概述了一种与之前发表的预测脑穿透性模型的平行分析,该模型利用了另一种 MDR1-MDCK 细胞系作为更好的脑穿透性预测指标,以及是否可以建立 啮齿动物数据、非人类灵长类动物 (NHP) 和人脑穿透性数据之间的相关性。在本文中,结合 参数和临床前 数据,强调了对结构和物理化学性质的分析,这是对之前已发表工作的延续。

相似文献

1
Harnessing Preclinical Data as a Predictive Tool for Human Brain Tissue Targeting.利用临床前数据作为预测人类脑组织靶向的工具。
ACS Chem Neurosci. 2021 Mar 17;12(6):1007-1017. doi: 10.1021/acschemneuro.0c00807. Epub 2021 Mar 2.
2
Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier.利用双人类转运体MDCKII-MDR1-BCRP细胞系评估血脑屏障处的外排作用。
Drug Metab Dispos. 2024 Jan 9;52(2):95-105. doi: 10.1124/dmd.123.001476.
3
Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.犬 P-糖蛋白缺陷型 MDCK II 细胞系的特征鉴定和验证及其在外排底物筛选中的应用。
Pharm Res. 2020 Sep 11;37(10):194. doi: 10.1007/s11095-020-02895-9.
4
Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration.验证人 MDR1-MDCK 和 BCRP-MDCK 细胞系以提高对脑穿透的预测。
J Pharm Sci. 2019 Jul;108(7):2476-2483. doi: 10.1016/j.xphs.2019.02.005. Epub 2019 Feb 20.
5
Prediction of Human Brain Penetration of P-glycoprotein and Breast Cancer Resistance Protein Substrates Using In Vitro Transporter Studies and Animal Models.运用体外转运体研究和动物模型预测 P-糖蛋白和乳腺癌耐药蛋白底物的人脑渗透。
J Pharm Sci. 2018 Aug;107(8):2225-2235. doi: 10.1016/j.xphs.2018.03.018. Epub 2018 Mar 30.
6
Experimental and Computational Methods to Assess Central Nervous System Penetration of Small Molecules.评估小分子进入中枢神经系统的实验和计算方法。
Molecules. 2024 Mar 13;29(6):1264. doi: 10.3390/molecules29061264.
7
Methods to optimize CNS exposure of drug candidates.优化候选药物中枢神经系统暴露的方法。
Bioorg Med Chem Lett. 2020 Dec 1;30(23):127503. doi: 10.1016/j.bmcl.2020.127503. Epub 2020 Aug 25.
8
Application of a high-resolution in vitro human MDR1-MDCK assay and in vivo studies in preclinical species to improve prediction of CNS drug penetration.应用高分辨率体外人 MDR1-MDCK 测定法和临床前物种的体内研究来改善对 CNS 药物渗透的预测。
Pharmacol Res Perspect. 2022 Feb;10(1):e00932. doi: 10.1002/prp2.932.
9
In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.体外评估多巴胺 β-羟化酶抑制剂与人 P-糖蛋白和乳腺癌耐药蛋白的相互作用。
Eur J Pharm Sci. 2018 May 30;117:35-40. doi: 10.1016/j.ejps.2018.02.006. Epub 2018 Feb 8.
10
Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.研究 MDR1 过表达细胞系,以利用体外外排活性为脑分布推导定量预测方法。
Eur J Pharm Sci. 2020 Jan 15;142:105119. doi: 10.1016/j.ejps.2019.105119. Epub 2019 Nov 1.

引用本文的文献

1
Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction.过表达MDR1的Abcb1基因敲除MDCKII细胞系在研究体外种属差异和脑穿透预测中的适用性
Pharmaceutics. 2024 May 29;16(6):736. doi: 10.3390/pharmaceutics16060736.
2
Experimental and Computational Methods to Assess Central Nervous System Penetration of Small Molecules.评估小分子进入中枢神经系统的实验和计算方法。
Molecules. 2024 Mar 13;29(6):1264. doi: 10.3390/molecules29061264.
3
Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.
多药耐药 1 型-EGFP 转染大鼠与人脑微血管内皮细胞系中 P-糖蛋白的定位、转运和功能的相似性和差异。
Fluids Barriers CNS. 2021 Aug 3;18(1):36. doi: 10.1186/s12987-021-00266-z.